As epigenetic modifiers of transcription, HDAC inhibitors also shift cellular profiles of gene expression to favor the induction of growth arrest and apoptosis in cancer cells, antagonize tumor angiogenesis, and enhance tumor cell immunogenicity through increased expression of MIC-A/B, MHC, and costimulatory molecules (52). Here, CD276 is linked to neoplasm.